CRANBURY, NJ — Solco Healthcare is proud to announce its FDA approval for Fenofibrate tablets, 48 mg and 145 mg, which is an AB-rated equivalent to Tricor® by Abbvie. Fenofibrate tablets are indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), Triglycerides and apolipoprotein B (Apo B), and to
Read more
CRANBURY, NJ – Solco Healthcare U.S. is proud to announce that the U.S. Food and Drug Administration (FDA) approved its generic equivalent of Hyzaar® Tablets (Losartan Potassium and Hydrochlorothiazide tablets), 50-12.5mg, 100-12.5mg and 100-25mg. The product is available now. Losartan Potassium-HCTZ is used to treat high blood pressure (hypertension). It is also used to lower the
Read more
CRANBURY, NJ – Solco Healthcare U.S. is proud to announce that the U.S. Food and Drug Administration (FDA) approved its generic equivalent of Cymbalta® Capsules (Duloxetine delayed-release capsules), 20mg, 30mg and 60mg. The product is available now. Duloxetine is used to treat major depressive disorder in adults. Duloxetine is also used to treat general anxiety
Read more
CRANBURY, NJ – August 11, 2016 – Solco Healthcare U.S. is proud to announce that the U.S. Food and Drug Administration (FDA) approved its generic equivalent of Vfend ® Tablets (Voriconazole Tablets), 50 mg and 200 mg. The Company is preparing for the commercialization of this product and expects to launch the product soon. “We
Read more